Luger SM - Search Results

1

A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

Perl AE, Kasner MT, Tsai DE, Vogl DT, Loren AW, Schuster SJ, Porter DL, Stadtmauer EA, Goldstein SC, Frey NV, Nasta SD, Hexner EO, Dierov JK, Swider CR, Bagg A, Gewirtz AM, Carroll M, Luger SM. Perl AE, et al. Among authors: luger sm. Clin Cancer Res. 2009 Nov 1;15(21):6732-9. doi: 10.1158/1078-0432.CCR-09-0842. Epub 2009 Oct 20. Clin Cancer Res. 2009. PMID: 19843663 Clinical Trial.

2

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.

Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM. Ratajczak MZ, et al. Among authors: luger sm. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11823-7. doi: 10.1073/pnas.89.24.11823. Proc Natl Acad Sci U S A. 1992. PMID: 1281545 Free PMC article.

3

Role of the KIT protooncogene in normal and malignant human hematopoiesis.

Ratajczak MZ, Luger SM, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM. Ratajczak MZ, et al. Among authors: luger sm. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1710-4. doi: 10.1073/pnas.89.5.1710. Proc Natl Acad Sci U S A. 1992. PMID: 1371882 Free PMC article.

4

The c-kit proto-oncogene in normal and malignant human hematopoiesis.

Ratajczak MZ, Luger SM, Gewirtz AM. Ratajczak MZ, et al. Among authors: luger sm. Int J Cell Cloning. 1992 Jul;10(4):205-14. doi: 10.1002/stem.5530100403. Int J Cell Cloning. 1992. PMID: 1379619 Free article. Review.

5

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.

Ratajczak MZ, Hijiya N, Catani L, DeRiel K, Luger SM, McGlave P, Gewirtz AM. Ratajczak MZ, et al. Among authors: luger sm. Blood. 1992 Apr 15;79(8):1956-61. Blood. 1992. PMID: 1562723 Free article.

6

Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line.

Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM. Clevenger CV, et al. Among authors: luger sm. J Biol Chem. 1995 Jun 2;270(22):13246-53. doi: 10.1074/jbc.270.22.13246. J Biol Chem. 1995. PMID: 7768923 Free article.

7

A functional analysis of protooncogene Vav's role in adult human hematopoiesis.

Luger SM, Ratajczak J, Ratajczak MZ, Kuczynski WI, DiPaola RS, Ngo W, Clevenger CV, Gewirtz AM. Luger SM, et al. Blood. 1996 Feb 15;87(4):1326-34. Blood. 1996. PMID: 8608221 Free article.

8

Bone marrow purging with oligodeoxynucleotides.

Gewirtz AM, Luger SM, Stadtmauer E. Gewirtz AM, et al. Among authors: luger sm. Blood. 1996 Aug 15;88(4):1517. Blood. 1996. PMID: 8695876 Free article. No abstract available.

9

4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.

Bird JM, Luger S, Mangan P, Edelstein M, Silberstein L, Powlis W, Ball J, Schultz DJ, Stadtmauer EA. Bird JM, et al. Bone Marrow Transplant. 1996 Aug;18(2):309-13. Bone Marrow Transplant. 1996. PMID: 8864439

10

Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer.

Morgan MA, Stadtmauer EA, Luger SM, Porter DL, Mangan PA, O'Neil P, Kamelle S, Benjamin I, Mick R, King SA, Rubin SC. Morgan MA, et al. Among authors: luger sm. Gynecol Oncol. 1997 Dec;67(3):272-6. doi: 10.1006/gyno.1997.4878. Gynecol Oncol. 1997. PMID: 9441774 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters